News Column

ExamWorks Reports Fourth Quarter and Full Year 2012 Financial Results

Page 4 of 1

LogoTracker

ATLANTA, GA -- (Marketwire) -- 02/27/13 -- ExamWorks Group, Inc. (NYSE: EXAM), a leading provider of independent medical examinations ("IMEs"), peer reviews, bill reviews and related services, today reported financial results for the fourth quarter and the full year of 2012.

Q4 and Full Year 2012 Highlights

•Revenues for the fourth quarter of 2012 were $139.6 million, an increase of $24.3 million, or 21.1%, over the year-ago quarter revenues of $115.3 million. Excluding the impact of acquisitions completed within the past twelve months, organic revenue grew by 5.4% over the prior year quarter.

•Pro forma revenues for the fourth quarter of 2012 were $142.6 million, an increase of $10.5 million, or 7.9%, over the year-ago quarter pro forma revenues of $132.1 million. Excluding the impact of currency, revenues would have grown by 6.9% over the prior year pro forma quarter. Pro forma revenues assume that acquisitions completed in 2011 and 2012 were completed on January 1, 2010 and 2011, respectively.

•Adjusted EBITDA for the fourth quarter of 2012 was $20.3 million (14.6% of revenues), an increase of $3.5 million, or 20.8%, over the year-ago quarter adjusted EBITDA of $16.8 million. Adjusted EBITDA is a non-GAAP measure that is described and reconciled to net loss below and is not a substitute for the GAAP equivalent.

•Revenues for the year ended December 31, 2012 were $521.2 million, an increase of $123.3 million, or 31.0%, over the prior year revenues of $397.9 million. Adjusted EBITDA for the year ended December 31, 2012 was $79.8 million, an increase of 26.1% over the prior year.

•Pro forma revenues for the year ended December 31, 2012 were $573.7 million, an increase of 5.6%, over the prior year pro forma revenues. Excluding the impact of currency, revenues would have grown by 5.9% over the prior year pro forma period. Pro forma adjusted EBITDA for the year ended December 31, 2012 was approximately $92 million.

•On December 19, 2012, we completed the acquisition of PMG, based in Southern California, for net cash consideration of $11.8 million. The PMG acquisition increases our market position in the workers' compensation market. On an annual basis, PMG generated revenues of approximately $12.5 million and adjusted EBITDA of approximately $2.5 million. In the fourth quarter of 2012, PMG contributed revenues and adjusted EBITDA of $285,000 and $52,000, respectively.

Commentary

Commenting on today's earnings announcement, James K. Price, Chief Executive Officer of ExamWorks, said: "During 2012, we continued to redefine the IME industry by raising customer expectations for quality and service. We are continuing our investment in developing cloud-based technology that keeps customer data safe and secure and better integrates our customers' processes with ours, thereby increasing connectivity and efficiency. With $574 million and approximately $92 million of pro forma run rate revenue and EBITDA and growing, we will continue raising the bar as we solidify our reputation as the global IME industry leader."

Richard E. Perlman, Executive Chairman of ExamWorks, said: "We are delighted with our financial and operating results, particularly the growth of our U.K. and Australian businesses, as well as the positive trends in our U.S. and Canadian businesses. Our performance reflects the solid execution of our integration, multiple brand, technology and geographic diversification strategies, which combined with our national account focus, will continue to drive increasing revenue and EBITDA growth in 2013 and beyond."

Financial Review

Revenues - For the three months ended December 31, 2012, revenues were $139.6 million, an increase of 21.1% over the $115.3 million in revenues in the fourth quarter of 2011. Excluding the impact of acquisitions completed within the past twelve months, organic revenue grew by 5.4% over the prior year quarter.

For the year ended December 31, 2012, revenues were $521.2 million, an increase of 31.0% over the $397.9 million in revenues in the comparable period of 2011. Excluding the impact of acquisitions completed in 2011 and 2012, organic revenue grew by 3.4% over the comparable prior year period.

Below is a table presenting our pro forma revenues and growth rates for each of the regions that we serve. The numbers presented below are pro forma for the effect of acquisitions completed in 2011 and 2012.


Pro Forma Revenues--------------------------------------------------------------------------- (In thousands except %) Three Months Ended December 31, Year Ended December 31, -------------------------- -------------------------- Change Change 2011 2012 (a) 2011 2012 (b) --------- --------- ------ --------- --------- ------ExamWorks U.S. $ 83,476 $ 82,673 (1.0)% $ 345,215 $ 352,817 2.2%United Kingdom 27,969 35,804 28.0% 111,083 131,279 18.2%Australia 13,252 16,936 27.8% 49,793 61,474 23.5%Canada 7,404 7,139 (3.6)% 37,190 28,166 (24.3)% --------- --------- ------ --------- --------- ------Total $ 132,101 $ 142,552 7.9% $ 543,281 $ 573,736 5.6% ========= ========= ====== ========= ========= ======(a) For the three months ended December 31, 2012 and excluding the impact of currency, our growth in the U.K. would have been 25.4%, our growth in Australia would have been 24.6%, the decline in Canada would have been (6.5)%, and our total growth would have been 6.9%.(b) For the year ended December 31, 2012 and excluding the impact of currency, our growth in the U.K. would have been 19.5%, our growth in Australia would have been 23.3%, the decline in Canada would have been (23.2)%, and our total growth would have been 5.9%.




In the fourth quarter of 2012, our U.S. businesses generated pro forma revenues of $82.7 million, a (1.0)% decline from the $83.5 million of pro forma revenues generated in the fourth quarter of 2011. In the fourth quarter, our U.S. revenues were negatively impacted by an estimated $3 million as a result of Hurricane Sandy. For the year ended December 31, 2012, our U.S. businesses generated revenues of $352.8 million, a 2.2% increase over the $345.2 million of pro forma revenues generated in the year ended December 31, 2011. The growth was largely due to increased volumes resulting from market share gains.

In the fourth quarter of 2012, our U.K. businesses generated revenues of $35.8 million, a 28.0% increase over the $28.0 million of revenues generated in the fourth quarter of 2011. For the year ended December 31, 2012, our U.K. businesses generated revenues of $131.3 million, an 18.2% increase over the $111.1 million of pro forma revenues generated in the year ended December 31, 2011. The growth was largely due to increased volumes resulting from market share gains.

In the fourth quarter of 2012, our Australian business generated pro forma revenues of $16.9 million, a 27.8% increase over the $13.3 million of pro forma revenues generated in the fourth quarter of 2011. For the year ended December 31, 2012, our Australian business generated pro forma revenues of $61.5 million, a 23.5% increase over the $49.8 million of pro forma revenues generated in the year ended December 31, 2011. The growth was primarily due to increased volumes resulting from market share gains and a change in sales mix.

In the fourth quarter of 2012, our Canadian businesses generated revenues of $7.1 million, a (3.6)% decline from the $7.4 million of pro forma revenues generated in the fourth quarter of 2011. For the year ended December 31, 2012, our Canadian businesses generated pro forma revenues of $28.2 million, a (24.3)% decline from the $37.2 million of pro forma revenues generated in the year ended December 31, 2011. Our Canadian businesses, which generate less than 5% of our total revenues, continue to be negatively impacted by the legislative changes in the province of Ontario, to a much lesser extent in the fourth quarter of 2012.

Costs of revenues - For the three months ended December 31, 2012, costs of revenues were $92.6 million, an increase of 21.8% over the $76.0 million in costs of revenues in the fourth quarter of 2011. The change was primarily due to the acquired costs of revenues for acquisitions completed in 2011 and 2012. Costs of revenues as a percentage of revenues for the fourth quarter of 2012 were 66.3% compared to 65.9% in the fourth quarter of 2011. Included in costs of revenues in the fourth quarter of 2011 and 2012 are $650,000 and $755,000 of share-based compensation expenses, respectively.

Selling, general and administrative expenses ("SGA") - For the three months ended December 31, 2012, SGA expenses were $28.9 million, an increase of 14.2% over the $25.3 million in SGA expenses in the fourth quarter of 2011. The change was primarily due to the acquired SGA expenses for acquisitions completed in 2011 and 2012. Included in SGA expenses in the fourth quarter of 2012 are $439,000 in share-based compensation expenses and $944,000 in acquisition-related transaction and other non-recurring costs. Included in SGA expenses in the fourth quarter of 2011 were $1.8 million in share-based compensation expenses and $413,000 in acquisition-related transaction costs and other non-recurring costs.

Depreciation and amortization expenses ("D&A") - For the three months ended December 31, 2012, D&A expenses were $16.3 million, an increase of 14.0% over the $14.3 million in D&A expenses in the fourth quarter of 2011. The change was primarily due to acquisitions completed in 2011 and 2012. For the three months ended December 31, 2012, depreciation expense was $1.5 million and amortization expense was $14.8 million.

Interest and other expenses, net - For the three months ended December 31, 2012, interest and other expenses, net were $7.8 million, an increase of 13.0% over the $6.9 million in interest and other expenses, net in the three months ended December 31, 2011. Included in interest and other expenses, net in the fourth quarter of 2012 are $7.8 million of interest expenses and deferred loan cost amortization.

Adjusted EBITDA - For the three months ended December 31, 2012, adjusted EBITDA was $20.3 million, an increase of 20.8% over the $16.8 million in adjusted EBITDA in the fourth quarter of 2011.

Adjusted EBITDA is a non-GAAP measure that is described and reconciled to net loss below and is not a substitute for the GAAP equivalent.

Other financial data - We generated $24.8 million of cash flow from operations in 2012, of which $9.7 million was generated in the fourth quarter. We ended the quarter with $8.6 million of cash on hand, approximately $385.0 million of total debt and total leverage of 4.15x. Our total debt consisted of $250.0 million of senior unsecured notes due July 2019, $99.9 million outstanding under the senior secured revolving credit facility, $34.5 million outstanding under the working capital facilities in the U.K., and $575,000 in seller subordinated notes. As of the end of the year, our committed availability under our credit facilities was approximately $180 million, of which approximately $55 million is immediately available and the balance of approximately $125 million is available to fund future acquisitions.

Business Outlook

ExamWorks is providing the following business outlook for the full year and the first quarter of 2013:

•Full year 2013 reported revenues are expected to increase organically by 5-7% from our 2012 pro forma revenues of approximately $574 million, excluding the effects of currency.

•Full year 2013 adjusted EBITDA margins are expected to range between 15.5% and 16.5% of reported revenues. The 50 bps change from our prior guidance is the result of significantly higher healthcare costs and employee enrollment into our benefit plans than originally anticipated. On a quarterly basis, adjusted EBITDA margins as a percentage of revenue will fluctuate between 15% and 17%.

•First quarter 2013 reported revenues are expected to range between $144 million and $148 million.

•First quarter 2013 reported adjusted EBITDA margins are expected to be approximately 15% of reported revenues.

•Starting in 2013, we intend to announce acquisitions as they close rather than guiding to an annual number. We believe that this will allow analysts and shareholders to more accurately and consistently model our expected results going forward.

About ExamWorks Group

ExamWorks Group, Inc. is a leading provider of independent medical examinations ("IMEs"), peer and bill reviews and related services. We help our clients manage costs and enhance their risk management processes by verifying the validity, nature, cause and extent of claims, identifying fraud and providing fast, efficient and quality IME services. ExamWorks is focused on providing clients a national presence while maintaining the local service and capabilities they need and expect.

Non-GAAP Financial Measures

In connection with the ongoing operation of our business, our management regularly reviews Adjusted EBITDA, a non-GAAP financial measure, to assess our performance. We define Adjusted EBITDA as earnings before interest, taxes, depreciation, amortization, acquisition-related transaction costs, share-based compensation expenses, and other non-recurring costs. We believe that Adjusted EBITDA is an important measure of our operating performance because it allows management, lenders, investors and analysts to evaluate and assess our core operating results from period to period after removing the impact of changes to our capitalization structure, acquisition related costs, income tax status, and other items of a non-operational nature that affect comparability.

We believe that various forms of the Adjusted EBITDA metric are often used by analysts, investors and other interested parties to evaluate companies such as ours for the reasons discussed above. Additionally, Adjusted EBITDA is used to measure certain financial covenants in our credit facility. Adjusted EBITDA is also used for planning purposes and in presentations to our Board of Directors as well as in our incentive compensation programs for our employees.

Non-GAAP information should not be construed as an alternative to GAAP information, as the items excluded from the non-GAAP measures often have a material impact on our financial results. Management uses, and investors should use, non-GAAP measures in conjunction with our GAAP results.

Below is a table presenting a reconciliation of Adjusted EBITDA to net loss, the most comparable GAAP measure, for each of the periods indicated.

Forward Looking Statements

Statements made in this press release that express ExamWorks' or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements, which ExamWorks intends to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. These statements often include words such as "may," "will," "should," "believe," "expect," "anticipate," "intend," "plan," "estimate," or the negative of these terms or other similar expressions that convey uncertainty of future events or outcomes. Forward-looking statements may include information concerning ExamWorks' possible or assumed future results of operations, including descriptions of ExamWorks' revenues, profitability, outlook and overall business strategy. You should not place undue reliance on these statements because they are subject to numerous uncertainties and factors relating to ExamWorks' operations and business environment, all of which are difficult to predict and many of which are beyond ExamWorks' control. Although ExamWorks believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many uncertainties and factors could affect ExamWorks' actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements, including but not limited to: our ability to implement our growth strategy and acquisition program; our ability to integrate completed acquisitions; our expansion into international markets; our ability to secure additional financing; regulation of our industry; our information technology systems; our ability to protect our intellectual property rights and other information; our ability to compete successfully with our competitors; our ability to retain qualified physicians and other medical providers for our medical panel; our ability to retain our clients; our ability to provide accurate health-related risk assessment analyses of data; our ability to retain key management personnel; and restrictions in our credit facility, senior notes indenture and future indebtedness. In addition, the risks discussed in our periodic reports, registration statements and other filings with the Securities and Exchange Commission could cause actual results to differ materially from the results anticipated by forward-looking statements.

You should keep in mind that any forward-looking statement made by ExamWorks herein, or elsewhere, speaks only as of the date on which made. ExamWorks expressly disclaims any intent, obligation or undertaking to update or revise any forward-looking statements made herein to reflect any change in ExamWorks' expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

ExamWorks will host a conference call to discuss the results and other matters at 5:00 p.m. Eastern Time. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (866) 713-8563 in the U.S. or (617) 597-5311 internationally with access code 50540404. A live webcast of the call is also accessible through the Investor Relations section of the company's web site at http://investorrelations.examworks.com/.

Following the conclusion of the call, a replay of the webcast will be available at the company's web site within two hours. Alternatively, a telephonic replay of the call will be available at 7:00 p.m. Eastern Time, and can be accessed until March 6th, 2013 at midnight Eastern Time, by calling (888) 286-8010 in the U.S. or (617) 801-6888 internationally, with access code 72477425.


EXAMWORKS GROUP, INC. AND SUBSIDIARIES Consolidated Statements of Operations (In thousands, except share and per share amounts) (Unaudited) For the three months For the year ended ended December 31, December 31, ------------------------ ------------------------ 2011 2012 2011 2012 ----------- ----------- ----------- -----------Revenues: $ 115,312 $ 139,637 $ 397,860 $ 521,237Costs and expenses: Costs of revenues 76,017 92,575 262,242 344,051 Selling, general and administrative expenses 25,348 28,868 84,133 113,510 Depreciation and amortization 14,286 16,306 47,439 58,551 ----------- ----------- ----------- ----------- Total costs and expenses 115,651 137,749 393,814 516,112 ----------- ----------- ----------- ----------- Income (loss) from operations (339) 1,888 4,046 5,125 ----------- ----------- ----------- -----------Interest and other expenses, net: Interest expense, net 6,558 7,814 15,480 27,968 Loss on early extinguishment of debt - - 621 - Other income - - - (226) Gain on interest rate swap (75) (56) (328) (225) Realized foreign currency loss 465 - 688 534 ----------- ----------- ----------- ----------- Total interest and other expenses, net 6,948 7,758 16,461 28,051 ----------- ----------- ----------- ----------- Loss before income taxes (7,287) (5,870) (12,415) (22,926)Income tax benefit (2,262) (3,187) (4,082) (7,987) ----------- ----------- ----------- ----------- Net loss $ (5,025) $ (2,683) $ (8,333) $ (14,939) =========== =========== =========== ===========Per Share Data: Net loss per share: Basic and diluted $ (0.15) $ (0.08) $ (0.25) $ (0.44) =========== =========== =========== =========== Weighted average number of common shares outstanding: Basic and diluted 34,223,906 34,287,093 33,975,658 34,141,098 =========== =========== =========== ===========Adjusted EBITDA $ 16,809 $ 20,332 $ 63,304 $ 79,789 =========== =========== =========== =========== EXAMWORKS GROUP, INC. AND SUBSIDIARIES Consolidated Balance Sheets (In thousands, except share and per share amounts) (Unaudited) December 31, -------------------------- ASSETS 2011 2012 ------------ ------------Current assets: Cash and cash equivalents $ 8,416 $ 8,627 Accounts receivable, net 144,041 144,676 Other receivables 40 21 Prepaid expenses 4,487 5,336 Deferred tax assets 1,640 16 Other current assets 1,173 1,213 ------------ ------------ Total current assets 159,797 159,889Property, equipment and leasehold improvements, net 8,918 10,333Goodwill 300,260 370,143Intangible assets, net 146,168 152,896Long-term accounts receivable, less current portion - 31,708Deferred tax assets, noncurrent - 4,173Deferred financing costs, net 11,458 10,258Other assets 438 1,101 ------------ ------------ Total assets $ 627,039 $ 740,501 ============ ============ LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities: Accounts payable $ 42,642 $ 46,940 Accrued expenses 28,410 35,995 Accrued interest expense 10,247 10,918 Deferred revenue 1,332 3,951 Current portion of subordinated unsecured notes payable 1,932 275 Current portion of contingent earnout obligation 91 91 Current portion of working capital facilities - 5,983 Other current liabilities 5,459 5,973 ------------ ------------ Total current liabilities 90,113 110,126Senior unsecured notes payable 250,000 250,000Senior secured revolving credit facility and working capital facilities, less current portion 44,063 128,402Long-term subordinated unsecured notes payable, less current portion 717 300Long-term contingent earnout obligation, less current portion 86 -Deferred tax liability, noncurrent 2,159 -Other long-term liabilities 1,977 7,525 ------------ ------------ Total liabilities 389,115 496,353 ------------ ------------Commitments and contingenciesStockholders' equity:Preferred stock, $0.0001 par value; Authorized 50,000,000 shares; no shares issued and outstanding at December 31, 2011 and 2012, respectively - -Common stock, $0.0001 par value; Authorized 250,000,000 shares; issued and outstanding 34,090,618 and 34,341,360 at December 31, 2011 and 2012, respectively 3 3Additional paid-in capital 268,162 285,938Accumulated other comprehensive income (loss) (1,429) 3,183Accumulated deficit (21,549) (36,488)Treasury stock, at cost: Outstanding 805,613 and 905,349 shares at December 31, 2011 and 2012, respectively (7,263) (8,488) ------------ ------------ Total stockholders' equity 237,924 244,148 ------------ ------------ Total liabilities and stockholders' equity $ 627,039 $ 740,501 ============ ============ EXAMWORKS GROUP, INC. AND SUBSIDIARIES Consolidated Statements of Cash Flows (In thousands) (Unaudited) For the year ended December 31, -------------------------- 2011 2012 ------------ ------------Operating activities: Net loss $ (8,333) $ (14,939) Adjustments to reconcile net loss to net cash provided by operating activities: Gain on interest rate swap (328) (225) Depreciation and amortization 47,439 58,551 Amortization of deferred rent (450) (82) Share-based compensation 7,834 13,756 Excess tax benefit related to share-based compensation - (2,853) Provision for doubtful accounts 2,297 2,852 Amortization of deferred financing costs 1,941 2,190 Deferred income taxes (6,364) (21,201) Loss on early extinguishment of debt 621 - Other - (31) Changes in operating assets and liabilities, net of effects of acquisitions: Accounts receivable (9,047) (24,666) Prepaid expenses and other current assets (1,801) (64) Accounts payable and accrued expenses (1,907) 8,300 Accrued interest expense 10,240 671 Deferred revenue and customer deposits (169) 2,425 Other liabilities (2,430) 93 ------------ ------------ Net cash provided by operating activities 39,543 24,777 ------------ ------------Investing activities: Cash paid for acquisitions, net (322,248) (108,970) Purchases of equipment and leasehold improvements, net (6,856) (5,841) Working capital and other settlements for acquisitions (6,710) 427 ------------ ------------ Net cash used in investing activities (335,814) (114,384) ------------ ------------Financing activities: Borrowings under credit facilities 278,000 170,640 Excess tax benefit related to share-based compensation - 2,853 Proceeds from the exercise of options and warrants 2,292 2,258 Borrowings under senior unsecured notes payable 250,000 - Purchases of treasury stock (9,421) (387) Payment of deferred financing costs (9,746) (1,074) Repayment of subordinated unsecured notes payable (2,421) (2,193) Net borrowings (repayments) under working capital facilities 35,621 (6,279) Repayment under credit facilities (273,000) (76,000) Other (440) (94) ------------ ------------ Net cash provided by financing activities 270,885 89,724 ------------ ------------Exchange rate impact on cash and cash equivalents 178 94Net increase (decrease) in cash and cash equivalents (25,208) 211Cash and cash equivalents, beginning of year 33,624 8,416 ------------ ------------Cash and cash equivalents, end of year $ 8,416 $ 8,627 ============ ============ EXAMWORKS GROUP, INC. AND SUBSIDIARIES Reconciliation to Adjusted EBITDA (In thousands) (Unaudited) For the three months For the year ended December 31, ended December 31, -------------------- -------------------- 2011 2012 2011 2012 --------- --------- --------- ---------Reconciliation of Adjusted EBITDA:Net loss $ (5,025) $ (2,683) $ (8,333) $ (14,939) Share-based compensation expense (1) 2,449 1,194 7,834 13,756 Depreciation and amortization 14,286 16,306 47,439 58,551 Acquisition-related transaction costs 403 385 3,107 1,655 Other non-recurring costs 10 559 878 702 Interest and other expenses, net 6,948 7,758 16,461 28,051 Benefit for income taxes (2,262) (3,187) (4,082) (7,987) --------- --------- --------- ---------Adjusted EBITDA $ 16,809 $ 20,332 $ 63,304 $ 79,789 ========= ========= ========= =========(1) Share-based compensation expense of $755,000 and $3.0 million is included in costs of revenues for the three and twelve months ended December 31, 2012 and the remainder is included in SGA expenses. Share- based compensation expense of $650,000 and $2.0 million is included in costs of revenues for the three and twelve months ended December 31, 2011 and the remainder is included in SGA expenses.





CONTACT:
ExamWorks Group, Inc.
J. Miguel Fernandez de Castro
404-952-2400
Senior Executive Vice President and Chief Financial Officer
investorrelations@examworks.com